The prescribed dosage for Sandostatin (octreotide acetate) may depend on a person’s individual treatment plan. Factors such as your medical history may affect your dosage of Sandostatin.
When Signifor LAR was approved in 2014, Novartis was suggesting it could become a replacement for its blockbuster Sandostatin LAR (octreotide acetate) depot product, which was making annual sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback